Gian Life Care informs about outcome of board meeting

07 Dec 2021 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Gian Life Care has informed that the Board of Directors at their meeting held on Monday, December 06, 2021, has approved incorporation/ formation of Wholly Owned Subsidiary Company to undertake the business of acquiring and running pathological labs and laboratories across the Country. The said proposal is expected to help the Company in covering new areas across all States and in turn would strengthen the financial position of the Parent Company. Details as required under Regulation 30 read with Schedule III of the Listing Regulations and the SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015 are attached as Annexure A to this letter.

The above information is a part of company’s filings submitted to BSE.

Gian Life Care Share Price

10.41 0.34 (3.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×